New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2014
10:00 EDTBIN, ARIA, RL, ARMS, TDC, MAS, GBCI, UNT, SQI, KR, BRS, FCH, LNKD, EXLPOn The Fly: Analyst Upgrade Summary
Bristow Group (BRS) upgraded to Overweight from Equal Weight at Barclays... Exterran Partners (EXLP) upgraded to Outperform from Neutral at Credit Suisse... Felcor Lodging (FCH) upgraded to Outperform from Market Perform at JMP Securities... Kroger (KR) upgraded to Overweight from Neutral at JPMorgan... LinkedIn (LNKD) upgraded to Outperform from Sector Perform at RBC Capital... Masco (MAS) upgraded to Hold from Underweight at KeyBanc... Ralph Lauren (RL) upgraded to Outperform from Market Perform at Wells Fargo... SciQuest (SQI) upgraded to Buy from Hold at Canaccord... Teradata (TDC) upgraded to Buy from Neutral at Longbow... ARIAD (ARIA) upgraded to Buy from Hold at Maxim... Unit Corp. (UNT) upgraded to Outperform from Sector Perform at Howard Weil... Amyris (AMRS) upgraded to Market Perform from Underperform at Cowen... Progressive Waste (BIN) upgraded to Outperform from Neutral at Credit Suisse... Glacier Bancorp (GBCI) upgraded to Buy from Neutral at DA Davidson.
News For BRS;EXLP;FCH;KR;LNKD;MAS;RL;SQI;TDC;ARIA;UNT;ARMS;BIN;GBCI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 21, 2015
07:36 EDTARIAARIAD anounces results of preclinical studies on Brigatinib at AACR meeting
ARIAD Pharmaceuticals announced the results of a series of preclinical studies on its investigational tyrosine kinase inhibitor, brigatinib at the American Association for Cancer Research Annual Meeting 2015. Brigatinib is in development for the treatment of patients with anaplastic lymphoma kinase positive metastatic non-small cell lung cancer, who are resistant to crizotinib. An oral presentation describes, for the first time, the design and chemical structure of brigatinib, discovered using ARIAD’s structure-based drug design platform. With the goal of designing a selective ALK inhibitor with broad-based activity against crizotinib-resistant mutants, ARIAD scientists advanced a series of novel compounds culminating in the identification of brigatinib. Brigatinib incorporates unique chemical-design features, including the distinctive use of a recognition element that confers favorable pharmacologic properties. Brigatinib has at least 10-fold greater potency than crizotinib against ALK+ NSCLC cell lines and was broadly active against clinically relevant crizotinib-resistant mutants in preclinical models. A poster presentation shows that brigatinib, at clinically achievable concentrations, has potent anti-tumor activity against a panel of 17 distinct ALK mutants known to confer resistance to other ALK inhibitors. In a separate study designed to model the occurrence of brain metastases in ALK+ lung cancer patients, brigatinib significantly reduced the tumor burden in mice with ALK+ brain tumors compared to the tumors in mice treated with crizotinib. Survival of brigatinib-treated mice was also markedly enhanced compared to the survival duration of crizotinib-treated mice.
April 20, 2015
14:49 EDTLNKDLinkedIn said to unveil Chinese social network product, Bloomberg reports
Subscribe for More Information
10:00 EDTBINOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:35 EDTBINProgressive Waste downgraded on growth outlook at RBC Capital
As noted earlier, RBC Capital downgraded Progressive Waste to Sector Perform from Outperform. The firm lowered its organic growth outlook for the company based on its channel checks which suggest a soft Q1 performance. Target to $31 from $34.
07:20 EDTARIAAmerican Association for Cancer Research to hold annual meeting
Subscribe for More Information
07:16 EDTLNKDAmerica's Growth Capital to hold a conference
Subscribe for More Information
07:06 EDTEXLPExterran Partners acquires compression assets from Exterran Holdings for $102.3M
Exterran Holdings, Inc. (EXH) and Exterran Partners, L.P. (EXLP) announced that Exterran Partners has acquired assets from Exterran Holdings for consideration valued at $102.3M, including customer contracts serving 60 customers together with 244 compressor units used to provide compression services under those contracts. Those compressor units represent approximately 151,000 horsepower of compression and approximately 4 percent of the combined U.S. contract operations business of Exterran Holdings and Exterran Partners. In addition, the acquisition includes 179 compressor units comprising approximately 66,000 horsepower previously leased from Exterran Holdings to Exterran Partners. The consideration paid to Exterran Holdings’ affiliates consisted entirely of Exterran Partners’ equity, composed of 3,963,138 common units and 80,341 general partner units. The transaction was approved by the conflicts committee of the board of directors of Exterran Partners’ managing general partner. The conflicts committee, which is composed entirely of independent directors, retained independent legal and financial advisors to assist it in evaluating the transaction.
06:24 EDTBINProgressive Waste downgraded to Sector Perform from Outperform at RBC Capital
April 19, 2015
12:41 EDTKRKroger, Dollar General, others can be bought and held for 3 years, Barron's says
Shares of PACCAR (PCAR), Lam Research (LRCX), Kroger (KR), Autoliv (ALV), Archer Daniels (ADM), and Dollar General (DG) should be bought and held for the next three years due to high return on invested capital, Barron's contends in a feature article. Reference Link
April 17, 2015
10:00 EDTTDCOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:47 EDTLNKDLinkedin May weekly volatility elevated into Q1 and outlook
Subscribe for More Information
08:43 EDTLNKDLinkedIn should be bought ahead of results, says Pacific Crest
Subscribe for More Information
07:36 EDTARIAARIAD presents updated clinical data on Brigatinib
Subscribe for More Information
06:06 EDTTDCTeradata initiated with a Neutral at DA Davidson
Subscribe for More Information
April 15, 2015
14:56 EDTLNKDLinkedIn VP of Marketing, Nick Besbeas, to leave at end of May, Re/code says
Subscribe for More Information
April 14, 2015
12:05 EDTLNKDMarketo engagement marketing platform to integrate with LinkedIn
Marketo (MKTO) announced it will partner with LinkedIn (LNKD) on a solution that connects LinkedIn's Lead Accelerator solution with Marketo's Engagement Marketing Platform. The combination "bridges the gap between digital, social and offline channels to enable marketers to engage in relevant conversations with customers wherever they are online," the company said. GE (GE) will pioneer the joint solution, Marketo announced.
11:16 EDTLNKDCredit Suisse's top Internet picks
Credit Suisse's top large-cap Internet picks remain Amazon.com (AMZN) for operating margin expansion and normalizing International growth, Facebook (FB) for underestimated long-term monitization potential from growing new products, and Google (GOOGL) for a slowdown in capex and narrowing of the mobile-desktop monetization gap. The firm's top small-cap picks are LinkedIn (LNKD) for the ramp of Sales Navigator and acceleration of Marketing Solutions and Yelp (YELP) because of reduced churn and increasing mobile traffic growth and ARPU.
April 13, 2015
14:31 EDTKRKroger ratifies agreement with UFCW 227
Subscribe for More Information
14:20 EDTARIANHS Scotland accepts ARIAD's Iclusig for use
Subscribe for More Information
07:10 EDTLNKDLinkedIn opens closed pilot for sharing app Elevate, TechCrunch says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use